A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma (Suspended)
8940 N. Wood Sage Rd | Peoria, IL 61615-7822
